💪 Studies Say 2-Minute Workouts Can Boost Longevity - Is It True?

Fitness in a Flash: The Rise of Exercise Snacks

If squeezing in a full workout feels unrealistic, science says small bursts of movement - “exercise snacks” - can still make a big difference. These short routines (think climbing stairs, bodyweight squats, or Tai Chi) repeated a few times a day can improve endurance and help maintain muscle, especially in older adults.

🔗 Read more

Why Muscle is the New Longevity Marker

Forget just living longer - the new goal is living stronger. “Musclespan” is the emerging term for how long your muscles stay functional as you age, and experts say it could rival blood pressure or cholesterol as a key health indicator. Maintaining muscle through strength training and protein intake helps protect mobility, metabolism, and immune health.

🔗 Read more

Weight Loss That Learns With You

Holi is taking on obesity with a data-driven approach that goes beyond willpower and medication. Their digital clinic combines GLP-1-based therapies with real-time AI-driven monitoring, allowing treatment plans to adapt dynamically based on user progress. The result? Reportedly 17% average weight loss over 12 months - nearly 50% more than drugs alone.

🔗 Read more

Decoding Our Defense System

Adaptam Therapeutics is developing new immunotherapies that disable the “cloaking” system tumors use to evade the immune system. Their focus? Immunosuppressive myeloid cells - a tough nut to crack in solid tumor treatment. Adaptam’s glyco-immune checkpoint modulators could unlock new doors for patients who don’t respond to traditional immunotherapies.

🔗 Read more

Tackling Brittle Bone Disease in Children

BOOST Pharma is developing BT-101, a stem cell-based therapy for osteogenesis imperfecta (OI), a rare condition that causes fragile bones in children. The treatment starts before or just after birth and aims to support bone growth from the inside out - improving not just fracture rates but overall development.

🔗 Read more

Tumor, Meet Target

Lithea is advancing a targeted drug delivery platform for bone cancer that puts chemo where it counts - inside the tumor, not the bloodstream. Their lead product, LIT1001, uses small implants that release doxorubicin directly into osteosarcoma sites. The goal: reduce side effects, boost impact, and shrink tumors more efficiently. With early FDA recognition and new funding in hand, they’re preparing for clinical trials that could change how we treat hard-to-reach cancers.

🔗 Read more

Shorter Queues, Smarter Systems

Athera Healthcare’s report reveals how AI is reshaping the way hospitals schedule surgeries, allocate resources, and manage procedural bottlenecks. Think predictive tools that know when a theatre will overrun or when a scanner is underused — and act on it. With NHS waitlists topping 7.42 million, even a 30% improvement in instrument turnaround can make a difference.

🔗 Read more

The €2.5 Billion Bet on Smarter Health Systems

GHO Capital’s latest healthcare fund is now Europe’s largest, clocking in at over €2.5 billion. But this isn’t just institutional muscle - it’s a signal that infrastructure-scale investment is catching up to the needs of modern care. From AI-powered R&D platforms to connected diagnostics, GHO’s portfolio spans the tools that could make healthcare faster, more coordinated, and more scalable.

🔗 Read more